CPAP Alternatives: Options Clinicians Discuss

Why CPAP is first line

Obstructive sleep apnea is a mechanical problem: the upper airway narrows or closes during sleep, breathing pauses, oxygen dips, and the brain briefly wakes to reopen the airway. CPAP answers it mechanically too — a steady stream of pressurized air splints the airway open from the inside, so the collapse never happens. That directness is why guidelines keep it first. A 2024 case vignette in the Annals of the American Thoracic Society restates the AASM position plainly: CPAP is first-line treatment for OSA, and nonadherence or intolerance — not lack of efficacy — is the main barrier (Annals ATS, 2024).

The guideline behind that position is specific about who should get it — and it shapes every cpap alternatives discussion that follows. AASM's 2019 PAP clinical practice guideline recommends PAP over no therapy for adults with OSA who have excessive sleepiness, impaired sleep-related quality of life, or comorbid hypertension — and recommends CPAP or APAP for ongoing treatment as a strong recommendation 1

Two good-practice requirements come with that recommendation, and both matter for the "alternatives" conversation. First, PAP therapy must rest on an OSA diagnosis made with objective sleep testing — not on snoring history or a questionnaire alone (AASM, 2019). Second, follow-up must include efficacy and usage data. If you are considering alternatives, those two requirements do not go away: any clinician will want the objective diagnosis and the record of what CPAP did or did not achieve before discussing what comes next.

It helps to name what "intolerance" actually covers, because the word does a lot of work on this page. People stop CPAP for mask discomfort and leaks, for claustrophobia with the mask, for dry mouth or nose, for noise, for the logistics of travel — and sometimes because the pressure feels wrong, which is itself a fitting problem worth one more appointment before it becomes a verdict. Telemonitoring-guided support at initiation is recommended precisely because early troubleshooting converts many "I can't do this" experiences into successful therapy (AASM, 2019 — secondary). The alternatives below are for people who have genuinely been through that process — not for people on night three.

When CPAP genuinely doesn't work, the list clinicians reach for is short — and each item has a gate. →

Options when CPAP is not tolerated

The 2024 Annals ATS case vignette gives the cleanest map of the cpap alternatives territory: when adherence fails, the alternatives on the clinical table are mandibular advancement devices, hypoglossal nerve stimulators, and bariatric surgery (Annals ATS, 2024). To that list this page adds one more category — prescription medicines, the newest arrival — because a 2024 trial and a subsequent FDA approval changed what clinicians can discuss. The table below orders them from least to most invasive, with the evidence strength of each stated plainly.

Evidence badges: 🟢 = guideline or large-trial backing; 🟡 = newer or narrower evidence. All options require clinician evaluation — none is self-prescribed.

Take each row in turn, because the cpap alternatives conversation is really four separate conversations. Oral appliances are the least invasive step: a 2015 joint guideline from the AASM and the American Academy of Dental Sleep Medicine recommends custom, titratable oral appliances over non-custom ones, and positions them as a standard option for patients who are CPAP-intolerant or prefer an alternate therapy — with dentist oversight as a guideline-level requirement 2

Note the two qualifiers that matter for this cpap alternatives row: custom and titratable. The boil-and-bite devices sold online are not what the guideline studied, and the guideline also calls for a sleep study while wearing the device — the appliance's effect gets measured, not assumed. That measurement requirement is the difference between a clinical therapy and a purchase.

Hypoglossal nerve stimulation is the most technically impressive option and the most gated. The STAR trial — 126 patients, published in the New England Journal of Medicine in 2014 — reported AHI falling from 29.3 to 9.0 at 12 months (a 68% reduction), with 66% of patients achieving at least a 50% reduction plus an AHI under 20, fewer than 2% serious adverse events, and benefit sustained at five-year follow-up 3

Those are strong numbers — and they are exactly why the candidacy gate exists for this cpap alternatives option: the trial selected specific patients, so the results apply to those patients. The eligibility box in the next section spells out the gate.

Prescription medicine is the newest category. In the SURMOUNT-OSA trial (469 adults, 2024), tirzepatide reduced AHI by 27.4 events per hour in non-PAP users and 30.4 in PAP users, versus 4.8 and 6.0 with placebo; disease resolution reached 43.0% and 51.5% versus 14.9% and 13.6% 4. On December 20, 2024, the FDA approved Zepbound for moderate-to-severe OSA in adults with obesity — the first prescription medicine approved for OSA itself.

Two cautions keep this cpap alternatives row honest. First, the approval is for OSA with obesity — it is not a general apnea medicine. Second, "prescription medicine" means clinician-managed by definition: dosing, side effects, and long-term use are medical decisions, and this page prescribes nothing. What the approval changes is the conversation a patient can have with their sleep clinician — it adds a row to the table, not a shortcut around it.

Bariatric surgery appears in the Annals vignette's alternatives list for poor adherence. It is the most invasive option here and the least like a "CPAP alternative" in the shopping sense: it is major surgery with its own candidacy criteria, evaluated by a surgical team, and discussed when severe obesity and OSA coincide. It belongs on the map so the map is complete — not because it is a next step for most readers.

Every rung has a gate — and the most famous gate is Inspire's. The eligibility box, verbatim from a hospital ENT department. →

Who qualifies and what comes first

This is the section the marketing skips, so it gets a box. The candidacy criteria below come from the UTHealth Houston ENT department's 2025 patient-education page on hypoglossal nerve stimulation — a hospital department describing its own selection process, reported here as a secondary source 5

Read the gate as a whole and the marketing picture inverts: most people searching "cpap alternatives" will not pass it. That is not a flaw in the therapy — the STAR trial's strong numbers came from exactly this selection — but it means the therapy and the gate are one package for this cpap alternatives option. Anyone promising the device without the workup is selling a different thing than the trial studied.

Oral appliances have a different, wider gate, but a gate nonetheless. The 2015 guideline path runs through a sleep dentist: custom device, titratable design, and — the step most skipped — a sleep study conducted while wearing the device, so its effect is measured rather than assumed (Ramar et al., 2015 — secondary). An off-the-shelf mouthguard bought online has none of these properties: not custom, not titratable, not measured. The guideline studied one thing; the internet sells another.

And what comes first is the same for every row of cpap alternatives: an OSA diagnosis made with objective sleep testing, then a CPAP trial with proper support and follow-up on efficacy and usage data, then — only then — the alternatives conversation with documented intolerance or inadequate benefit (AASM, 2019). Skipping straight to alternatives is skipping the best-studied option on the basis of an unsupported first week. If testing itself is the unknown, start with how is sleep apnea tested? — and if you are unsure whether your symptoms even point to apnea rather than snoring, snoring or sleep apnea — how do you tell the difference? sorts that first.

Now the aisle the guidelines never mention: the over-the-counter "alternatives." →

The myth-bust: over-the-counter replacements

Search "sleep apnea treatment without cpap" and the results split in two: the clinical list mapped above, and a long tail of over-the-counter products — nasal dilators, mouth tape, positional alarms, "anti-snore" pillows, herbal sprays. Here is the honest sorting. The AASM-aligned alternatives list in the 2024 case vignette contains mandibular advancement devices, hypoglossal nerve stimulators, and bariatric surgery (Annals ATS, 2024). Nasal strips are not on it. Mouth tape is not on it. No pillow is on it — which is why our companion page can a pillow help sleep apnea? what guidelines say draws that boundary in detail.

The distinction that matters in the cpap alternatives aisle is snoring versus apnea. Some OTC products address snoring — the sound — for some people, some of the time. Snoring is a symptom; apnea is a disorder of repeated breathing pauses with oxygen dips. A product that quiets the sound without addressing the pauses can make the problem harder to notice while leaving it untreated. That is why the guideline sequence starts with objective testing: it measures the pauses, not the noise. If your question is really "do I have apnea or just snoring," the testing page and the snoring-vs-apnea page linked above are the right next reads — before any product page.

A special note on mouth tape, because it is having a marketing moment among cpap alternatives searches: taping the mouth shut during sleep is not an apnea treatment in any guideline, and encouraging nasal breathing by sealing the mouth raises obvious safety questions for anyone whose nose is congested — which is many people, many nights. Our site's standing policy is safety-first on this topic: no mouth-taping recommendation appears here, and none should be inferred. Anything that restricts breathing during sleep deserves a clinician's input first, not a product review.

Three questions everyone asks next — cured, gone on its own, worse over time — answered without the usual hand-waving. →

Can sleep apnea be cured, go away, or get worse?

Can sleep apnea be cured? The careful answer — the one missing from most cpap alternatives marketing — is that clinicians talk about management and control rather than cure. CPAP does not cure apnea; it prevents the airway collapse each night it is used, which is why stopping brings the pauses back. Some interventions change the underlying picture more durably — sustained major weight loss can reduce severity substantially, and procedures like hypoglossal nerve stimulation provide ongoing therapy without nightly equipment — but "cured, walk away, never think about it again" is not the framing any guideline uses. Expect long-term management with periodic review, and treat any product promising a permanent cure with the skepticism the evidence demands.

Can sleep apnea just go away on its own? Typically, no. Apnea is tied to airway anatomy, muscle tone during sleep, and factors like weight — none of which resolve spontaneously in most adults. Waiting without evaluation is the one option no guideline lists, because untreated apnea is associated with cardiovascular and metabolic risks that accumulate quietly. The right move for suspected apnea is testing, not waiting.

Does sleep apnea get worse over time? It can, and that possibility is part of why the cpap alternatives conversation should happen with a clinician rather than a shopping cart. Weight gain is the most common driver of progression, and aging changes muscle tone in ways that do not help. This is one reason the AASM good-practice statements call for follow-up with efficacy and usage data rather than a single prescription left unreviewed for years (AASM, 2019). If symptoms creep back — louder snoring, returning daytime sleepiness, morning headaches — that is a follow-up appointment, not a failure.

For readers whose CPAP struggle is specifically about side sleeping and mask leaks rather than about CPAP as a concept, the alternatives list may be premature: how do you sleep on your side with a CPAP mask? covers the comfort side of that problem, and positional sleep apnea explained: back vs side sleeping covers when position itself changes the numbers. Many "CPAP isn't working" stories are really "CPAP isn't comfortable yet" stories — and comfort has its own fixes.

The exact questions people type into Google about this — answered in under 80 words each. →

How to talk to your doctor about alternatives

Most people researching cpap alternatives eventually sit across from a sleep clinician, and that appointment has a structure whether you prepare for it or not. Preparing changes what you get out of it. The clinician's first job is to confirm the diagnosis is current — sleep studies age, weight changes, and symptoms evolve — and their second is to review what CPAP achieved, because "intolerant" and "inadequately treated" lead to different next steps. Bring the study report if you have it, and bring the machine data: hours used, leak numbers, and the pressure story. "I tried it and hated it" is a starting point; the data turns it into a clinical picture.

Bring a written list of what you actually tried, too. Which masks, for how long, what the fitter adjusted, whether humidification was tried, whether a different pressure mode was discussed. This is the documentation of intolerance the candidacy gates ask for, and reconstructing it from memory in the appointment wastes the appointment. If you never got telemonitoring-guided support at initiation — the early troubleshooting the 2019 guideline recommends — say so; some clinicians will want to run that process properly before declaring CPAP a failure (AASM, 2019 — secondary).

Then ask the questions that separate the cpap alternatives rows. If oral appliance sleep apnea treatment comes up, ask: who does the fitting, is the device custom and titratable, and will there be a sleep study while wearing it? If the answer to that last question is no, you are not being offered the guideline version. If hypoglossal nerve stimulation who qualifies is the question on your mind, ask directly: do I meet the AHI and anatomy gates, who does the sleep endoscopy, and what does the workup cost in time — because the evaluation itself is a multi-step process, not a single yes-or-no visit. If medicine is discussed, ask about the obesity criterion, side effects, and what long-term use looks like; a prescription is a commitment, not a trial.

That last question matters more than it sounds. Every alternative on this page — device, implant, medicine, surgery — needs its own follow-up measurement, just as CPAP needed efficacy and usage data. An alternative without a follow-up plan is a treatment without a feedback loop, and the guidelines' insistence on measurement applies all the way down the ladder. The goal of the appointment is not to collect an option; it is to leave with a measured plan.

The exact questions people type into Google about this — answered in under 80 words each. →